Why Is AVEVA Group plc Surging Higher Today?

AVEVA Group plc (LON:AVV) has announced a complex reverse takeover deal that significantly changes the outlook for shareholders.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

Shares in industrial software firm AVEVA Group (LSE: AVV) rose by as much as 30% this morning, after the firm announced a major deal with French firm Schneider Electric.

What’s happened?

Aveva will acquire a selection of software assets from Schneider Electric, including the software assets formerly belonging to Invensys, the FTSE 250 firm acquired by Schneider in 2013. The assets will be acquired on a debt-free and cash-free basis.

The assets will be acquired on a debt-free and cash-free basis, but this isn’t a simple acquisition. On completion of the deal, Schneider will pay £550m in cash to Aveva and receive 74m new Aveva shares, giving Schneider a 53.5% majority stake in Aveva.

Aveva’s existing shareholders will share the £550m plus some of Aveva’s net cash, resulting in a whopping special dividend that I estimate at around £10 per share.

Why?

Aveva says the purpose of the deal is to create “a global leader in industrial software” with sufficient scale to play a leading role in key markets.

The resulting company will have a much larger and more comprehensive product portfolio of industrial software. Aveva specialises in asset management and operational management software for large engineering businesses, and says this deal will enhance its position in sectors including oil and gas, chemicals and pharmaceuticals.

Geographic coverage will also improve, with 36% of revenues now expected to come from the Americas, compared to just 18% for the current Aveva business.

Big rise in profits

The enlarged Aveva is expected to have annual revenue of £534m and adjusted earnings before interest, tax and amortisation (EBITA) of £130m. These figures are more than double those the firm reported last year, when sales totalled £208.7m and adjusted pre-tax profits were £62.1m.

However, shareholders need to consider that the firm’s share count will also rise sharply, climbing by 115% to 138m. My rough calculations suggest that last year’s adjusted earnings for the combined firm, using the figures provided by Aveva today, could be around 65-70p per share. At the current share price of 2,275p, this gives Aveva a trailing P/E of about 33.

Before today’s deal, Aveva traded on a trailing P/E of 24, so the market seems to be pricing in considerable new growth as a result of this deal.

Is Aveva a buy?

Once this deal completes, Schneider will have a 53.5% shareholding in Aveva. As a majority shareholder, Schneider will have a lot of influence over Aveva. For example, Schneider could choose to vote against Aveva’s dividend.

Schneider might also choose to sell Aveva to another owner, or to buy-out Aveva’s minority shareholders during a tough period. In such a scenario, Aveva’s share price could be much lower than it is today. This could force minority shareholders to sell for a loss, against their will.

Schneider has undertaken not to do anything of this kind for at least two years, but it does seem likely to me that the firm will eventually want to take full control of Aveva, or sell it.

Aveva shares don’t look cheap to me, either. Earnings per share have only risen by an average of 4.4% per year since 2010. Yet before today’s announcement, Aveva was trading on a demanding 2016 forecast P/E of 23.

Investors will have to decide for themselves whether they believe the new Aveva’s growth prospects are strong enough to justify a premium rating.


Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Abstract bull climbing indicators on stock chart
Investing Articles

Could the Chancellor’s Leeds Reforms trigger a bull market for UK stocks?

More competitive lending and greater interest in shares could help kick start growth for UK businesses. But could it also…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

I think this AI stock could double before Palantir

Palantir stock is up almost 100% this year. As a result, it now sports a market cap of $350bn meaning…

Read more »

Elevated view over city of London skyline
Investing Articles

As the FTSE 100 hits an all-time high, is it time to reconsider the S&P 500?

Christopher Ruane explains why a surging FTSE 100 has not yet made him focus more on the potential of S&P…

Read more »

GSK scientist holding lab syringe
Investing Articles

The FTSE 100 sits at a record high. But some stocks still look dirt cheap!

The usually sluggish FTSE 100 is having a surprisingly good year. But our writer feels there are still potential bargains…

Read more »

Close-up of British bank notes
Investing Articles

With a £20k Stocks and Shares ISA, here are 3 ways an investor could target a £2k annual passive income

Our writer thinks there is more than one way to try and skin a cat when it comes to earning…

Read more »

Businessman using pen drawing line for increasing arrow from 2024 to 2025
Investing Articles

Up 350% in 3 years but my favourite FTSE growth share is still on a low P/E of just 10!

Harvey Jones can't tear his eyes away from this former penny stock turned growth share superpower. But can it carry…

Read more »

Santa Clara offices of NVIDIA
Investing Articles

Up 83% in months, could Micron stock be the next Nvidia?

Chipmaker Micron Technology's stock price has surged by over 80% in just a few months. Could this be a possible…

Read more »

Tesla car at super charger station
US Stock

£1k invested in Tesla stock at the start of the year is currently worth…

Jon Smith reveals the performance of Tesla stock in 2025 and explains why he doesn't believe the move lower is…

Read more »